AbbVie Continues To Pursue Irish Drugmaker Shire With Higher Offer - Presented by: The Aol. On Network

Three rejections and still trying. That sums up U.S. drugmaker AbbVie's pursuit of the London listed bio-pharmaceutical giant, Shire. After AbbVie's latest unsuccessful $46 billion bid to gain control of Shire, AbbVie upped it's offer to $51 billion. Shire CEO Flemming Ornskov previously said that he was not against a buyout, but needed the right price. So is $51 billion the right price?



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 117.605 8.47 ▲ 7.76%
BAC $ 15.415 0.22 ▼ 1.38%
YHOO $ 48.93 0.94 ▲ 1.96%
MSFT $ 42.18 0.48 ▼ 1.13%
PBR $ 6.795 0.66 ▼ 8.79%
BABA $ 99.71 3.23 ▼ 3.14%
T $ 33.135 0.33 ▲ 0.99%
X $ 24.44 3.17 ▲ 14.90%

As of 1/28/2015, 12:34 PM
More Most Active